Users Stopping Slimming Injections Put On Pounds at a Quadrupled Rate Than Dieters

Fresh analysis suggests that individuals who stop using blockbuster weight-loss injections like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who stop traditional lifestyle regimens.

Research printed in a major health publication demonstrates that while obese people can lose a large proportion of their body weight while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month once they quit.

"Users purchasing these treatments need to be aware of the risk of quick weight regain when the treatment concludes," cautioned expert Dr. Susan Jebb.

Such speed of regain implies a reversion to original mass in about 18 months.

Analyzing Treatments

The analysis, which reviewed dozens of studies involving thousands of patients, compared the effects of GLP-1 agonists with other pills.

The team note that individuals who lose weight through lifestyle changes alone generally have a less rapid creep back—perhaps 100 grams monthly—post-intervention.

The Reason for the Quick Regain

Experts believe the mode of action of the injections explains the heightened weight return.

The injections mimic a body's own chemical called GLP-1, which moderates feelings of fullness.

"Long-term administration of the hormone levels far above than the body's typical production could lead to the system to produce less of its endogenous hormone, and could lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this medication means appetite is no longer kept in check, making excessive eating much more probable."

An Ongoing Condition?

The NHS suggest the injections for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

Professionals say that, considering the significant potential of weight regain, the treatment might need to be long-term.

This perspective is echoed by drug manufacturers, who note that the results "underscore the long-term character of obesity," akin to managing conditions like hypertension.

Patient Accounts

Individuals who have come off the jabs explain a intense resurgence of cravings.

"It was like something activating and I was suddenly extremely hungry," recalled one woman.

This difficulty is exacerbated if users have not adopted permanent lifestyle or habit changes during therapy.

Growing Use

Recent estimates show that a significant number of adults in the UK have tried these injections in the past year, with demand being substantial.

• Use is more common among females compared to men.
• The 40s and 50s demographic shows the greatest usage rates.
• A large proportion obtain the drugs through private healthcare rather than public health services.

Finally, researchers emphasize that while these medications are powerful agents for shedding pounds, they are not a standalone cure and long-term success relies on ongoing behavioural support.